Cd25 apc
CD25-APC is a fluorochrome-conjugated antibody that binds to the CD25 antigen, also known as the interleukin-2 receptor alpha chain. It is commonly used in flow cytometry applications for the identification and analysis of CD25-positive cells.
Lab products found in correlation
11 protocols using cd25 apc
In Vitro Assessment of CAR-T Cell Efficacy
Immune Cell Profiles in Pregnancy and Multiple Sclerosis
Non-specific sites of 3 × 106 cells were blocked with rabbit immunoglobulins G (IgG, Sigma-Aldrich), and cells were then incubated with fluorochrome-conjugated monoclonal Ab (mAb) and isotype–matched negative controls for 10 min at 4°C. The following anti-human mAbs were used: CD163 Phycoerythrin (PE) and CD14 Fluorescein isothiocyanate (FITC) for M2 monocytes, CD3 allophycocyanin (APC)-Vio770, CD16 FITC and CD56 APC for NK cells, CD3 APC-Vio770, CD4 PE-Vio770 and CD8 FITC for T cells, CD4 PE-Vio770, CD25 APC, and CD127 FITC for Treg (Miltenyi Biotec, Bergisch Gladbach, Germany). Living cells identified by propidium iodide (Sigma-Aldrich) exclusion were gated according to their light-scatter properties to exclude cell debris. Samples were analyzed using a CyAn ADP, running Summit 4.3 software (Beckman Coulter, Brea, CA, USA). The gating strategy is shown in the
Multicolor Flow Cytometry of PBMC
We performed intracellular staining for IL-2, IL-4, IL-17, IFN-g, and TNF-a together with extracellular markers for CD4+, CD8+, and CD19+. Cells were fixed and permeabilized using Intracellular Fixation and Permeabilization Buffer Set (eBioscience) according to the manufacturer’s instructions.
Data were acquired (> 1 × 106 events) on a 3-laser FACSLyric flow cytometer (BD Biosciences) and analyzed with FlowJo® software.
Flow Cytometry Analysis of Immune Cells
Quantifying Immune Cell Subsets in Spleen
Regulatory T-Cell Levels in Autoimmune Diseases
For Treg evaluation, PBMCs were incubated for 5 min at 4°C with rabbit immunoglobulins G (IgG, Sigma-Aldrich) to block non-specific sites and then for 10 min at 4°C with fluorochrome-conjugated monoclonal Ab (mAb) or isotype-matched negative controls. For Treg determination the following antihuman mAbs were used: CD4 PE-Vio770, CD25 APC, and CD127 FITC (Miltenyi Biotec, Bergisch Gladbach, Germany). Living cells identified by propidium iodide (Sigma-Aldrich) exclusion were gated according to their light-scatter properties to exclude cell debris. Samples were analyzed using a CyAn ADP, running Summit 4.3 software (Beckman Coulter, Brea, CA, USA).
Isolation of Human Immune Cell Subsets
Expansion of Regulatory T Cells
Treg Expansion 1 × 10 5 isolated Tregs were cultured in 100 μL TexMACS TM good manufacturing practice (GMP) cell culture medium (Miltenyi Biotech, Germany) supplemented with 10% FBS (PAN-Biotech, Germany), 100 nM rapamycin (Rapamune ® , Wyeth, USA), 500 IU/mL human recombinant IL-2 and containing 50 IU/mL pen-strep (PAN-Biotech, Germany), 1 mM sodium pyruvate (Sigma-Aldrich, USA), 25 mM HEPES (Sigma-Aldrich, USA), and activated with anti-CD3/CD28-coated beads (1:4 cell: bead ratio, Treg Expansion Kit; Miltenyi Biotec) in 48 well-plate (Sigma-Aldrich, USA) for 5 days [2, 21] . Confluent wells were split into new plates, and 100 IU/mL rIL-2 was added at day 1 and replenished every second day.
Dornase alfa and MgSO4 Effects on PBMC
Following the isolation of peripheral mononuclear cells (PBMC) by overlaying blood on Ficollpaque plus (GE Healthcare), the serially diluted (300 U/mL, 100 U/mL, 30 U/mL, 10 U/mL, 3 U/mL) Dornase alfa (Pulmozyme®, Roche, USA) and 420 g/mL MgSO 4 (Magnesium Sulphate 15% Onfarma, TR) were incubated with the PBMCs for 48hr in T cell medium (6% Human AB Serum and 1% Pen/Strep, Texmacs medium). Immune cell subtypes and their activation levels were determined by Miltenyi MACSQuant flow cytometry analysis using CD3-PE, CD19-PE.cy7, CD56-FITC, CD4-Viogreen, CD8-Vioblue, CD25-APC and CD107a-PE.cy5.5 (Miltenyi).
Comprehensive Immune Cell Profiling by Flow Cytometry
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!